Inventor · disambiguated record
Michael T. Certo
Also filed as: CERTO MICHAEL · CERTO MICHAEL T
15 granted patents·7 pending applications·90 citations·filing 2012–2025
92Inventor score
Files withSEATTLE CHILDRENS HOSPITAL62SEVENTY BIO INC5BLUEBIRD BIO INC5SEATTLE CHILDREN'S HOSPITAL3NOVO NORDISK AS1
Top patents by PatentIndex Score
22 records- 0194US10457731B2Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2018·Granted Oct 29, 2019·19 cites·27 claims
- 0293US10428142B2Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2015·Granted Oct 1, 2019·19 cites·4 claims
- 0393US8673557B2Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSCHARENBERG ANDREW M·Filed 2012·Granted Mar 18, 2014·21 cites·14 claims
- 0492US10196444B2Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2014·Granted Feb 5, 2019·22 cites·27 claims
- 0589US12378546B2Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSEATTLE CHILDRENS HOSPITAL·Filed 2023·Granted Aug 5, 2025·0 cites·17 claims
- 0689US11530265B2Multipartite signaling proteins and uses thereof2SEVENTY BIO INC·Filed 2019·Granted Dec 20, 2022·3 cites·26 claims
- 0788US11779654B2PCSK9 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2018·Granted Oct 10, 2023·5 cites·15 claims
- 0886US10745690B2Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSEATTLE CHILDREN'S HOSPITAL·Filed 2018·Granted Aug 18, 2020·1 cites·17 claims
- 0980US2023287111A1Multipartite signaling proteins and uses thereof2SEVENTY BIO INC·Filed 2022·Application pending·0 cites
- 1078US11959073B2Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSEATTLE CHILDRENS HOSPITAL·Filed 2021·Granted Apr 16, 2024·0 cites·20 claims
- 1178US11873479B2Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSEATTLE CHILDRENS HOSPITAL·Filed 2021·Granted Jan 16, 2024·0 cites·16 claims
- 1276US2024189454A1Pcsk9 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2023·Application pending·0 cites
- 1370US10947529B2Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSEATTLE CHILDRENS HOSPITAL·Filed 2016·Granted Mar 16, 2021·0 cites·36 claims
- 1470US2025262323A1Pcsk9 endonuclease variants, compositions, and methods of useNOVO NORDISK AS·Filed 2025·Application pending·0 cites
- 1569US11008565B2Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSEATTLE CHILDRENS HOSPITAL·Filed 2016·Granted May 18, 2021·0 cites·68 claims
- 1669US10745688B2Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSEATTLE CHILDREN'S HOSPITAL·Filed 2016·Granted Aug 18, 2020·0 cites·21 claims
- 1769US10745689B2Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSEATTLE CHILDREN'S HOSPITAL·Filed 2016·Granted Aug 18, 2020·0 cites·21 claims
- 1867US10995332B2Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSEATTLE CHILDRENS HOSPITAL·Filed 2015·Granted May 4, 2021·0 cites·61 claims
- 1965US2014227244A1Coupling endonucleases with end-processing enzymes drives high efficiency gene disruptionSEATTLE CHILDREN S RES INST·Filed 2014·Application pending·0 cites
- 2065US2020071399A1Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2019·Application pending·0 cites
- 2155US2024218351A1Single stranded rna purification methods2SEVENTY BIO INC·Filed 2022·Application pending·0 cites
- 2236US2019161530A1Chimeric antigen receptor t cell compositionsBLUEBIRD BIO INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael T. Certo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →